On the origin of serum CD26 and its altered concentration in cancer patients

Cancer Immunology, Immunotherapy

Volumn 58, Issue 11, 2009, Pages 1725-1749

  Cordero, Oscar J ^a   Salgado, Francisco J ^a   Nogueira, Montserrat ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Cancer; Chemokines; Dipeptidyl peptidase IV; Incretins; sCD26; T cells

Indexed keywords

DIPEPTIDYL PEPTIDASE IV; INSULIN; DPP4 PROTEIN, HUMAN; PROTEINASE INHIBITOR;

CANCER PATIENT; CARCINOGENICITY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNE RESPONSE; LIVER; LYMPHOCYTE; NEOPLASM; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; BLOOD; DRUG ANTAGONISM; ENZYMOLOGY; PHYSIOLOGY;

ANTIGENS, CD26; HUMANS; NEOPLASMS; PROTEASE INHIBITORS;

EID: 70349774693     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-009-0728-1     Document Type: Review

References (354)

1. WN Dinjens et al. 1989 Distribution of adenosine deaminase complexing protein (ADCP) in human tissues J Histochem Cytochem 37 12 1869 1875
2. AM Lambeir et al. 2003 Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV Crit Rev Clin Lab Sci 40 3 209 294
3. S Hartel et al. 1988 Dipeptidyl peptidase (DPP) IV in rat organs. Comparison of immunohistochemistry and activity histochemistry Histochemistry 89 2 151 161
4. DA Fox et al. 1984 Ta1, a novel 105 KD human T cell activation antigen defined by a monoclonal antibody J Immunol 133 3 1250 1256
5. M Hegen et al. 1990 The T cell triggering molecule Tp103 is associated with dipeptidyl aminopeptidase IV activity J Immunol 144 8 2908 2914
6. T Yamabe et al. 1997 Induction of the 2B9 antigen/dipeptidyl peptidase IV/CD26 on human natural killer cells by IL-2, IL-12 or IL-15 Immunology 91 1 151 158
7. VK Hopsu-Havu GG Glenner 1966 A new dipeptide naphthylamidase hydrolyzing glycyl-prolyl-beta-naphthylamide Histochemie 7 3 197 201
8. WP Schrader AR Stacy 1977 Purification and subunit structure of adenosine deaminase from human kidney J Biol Chem 252 18 6409 6415
9. ME Morrison et al. 1993 A marker for neoplastic progression of human melanocytes is a cell surface ectopeptidase J Exp Med 177 4 1135 1143
10. J Kameoka et al. 1993 Direct association of adenosine deaminase with a T cell activation antigen, CD26 Science 261 5120 466 469
11. E Boonacker CJF Van Noorden 2003 The multifunctional or moonlighting protein CD26/DPPIV Eur J Cell Biol 82 2 53 73
12. I De Meester et al. 1999 CD26, let it cut or cut it down Immunol Today 20 8 367 375
13. K Ohnuma NH Dang C Morimoto 2008 Revisiting an old acquaintance: CD26 and its molecular mechanisms in T cell function Trends Immunol 29 6 295 301
14. MD Gorrell et al. 2001 CD26: a multifunctional integral membrane and secreted protein of activated lymphocytes Scand J Immunol 54 3 249 264
15. P Busek R Malík A Sedo 2004 Dipeptidyl peptidase IV activity and/or structure homologues (DASH) and their substrates in cancer Int J Biochem Cell Biol 36 3 408 421
16. A Sedo et al. 2008 Dipeptidyl peptidase-IV and related molecules: markers of malignancy? Expert Opin Med Diagn 2 6 1 13
17. FJ Salgado et al. 2003 A role for interleukin-12 in the regulation of T cell plasma membrane compartmentation J Biol Chem 278 27 24849 24857
18. R Pacheco et al. 2005 CD26, adenosine deaminase, and adenosine receptors mediate costimulatory signals in the immunological synapse Proc Natl Acad Sci USA 102 27 9583 9588
19. X Ren et al. 2005 Transmembrane interaction mediates complex formation between peptidase homologues and Kv4 channels Mol Cell Neurosci 29 2 320 332
20. G Ghersi et al. 2006 The protease complex consisting of dipeptidyl peptidase IV and seprase plays a role in the migration and invasion of human endothelial cells in collagenous matrices Cancer Res 66 9 4652 4661
21. W-T Chen T Kelly 2003 Seprase complexes in cellular invasiveness Cancer Metastasis Rev 22 2-3 259 269
22. HC Cheng M Abdel-Ghany BU Pauli 2003 A novel consensus motif in fibronectin mediates dipeptidyl peptidase IV adhesion and metastasis J Biol Chem 278 27 24600 24607
23. LR Henry et al. 2007 Clin Cancer Res 13 6 1736 1741
24. JD Cheng et al. 2005 Abrogation of fibroblast activation protein enzymatic activity attenuates tumor growth Mol Cancer Ther 4 3 351 360
25. A Morita et al. 1983 Intestinal assimilation of a proline-containing tetrapeptide. Role of a brush border membrane postproline dipeptidyl aminopeptidase IV J Clin Invest 72 2 610 616
26. C Tiruppathi et al. 1993 Genetic evidence for role of DPP IV in intestinal hydrolysis and assimilation of prolyl peptides Am J Physiol 265 1 Pt 1 G81 G89
27. M Alfalah R Jacob HY Naim 2002 Intestinal dipeptidyl peptidase IV is efficiently sorted to the apical membrane through the concerted action of N- and O-glycans as well as association with lipid microdomains J Biol Chem 277 12 10683 10690
28. M Alfalah et al. 2005 A novel type of detergent-resistant membranes may contribute to an early protein sorting event in epithelial cells J Biol Chem 280 52 42636 42643
29. G Vanhoof et al. 1995 Proline motifs in peptides and their biological processing FASEB J 9 9 736 744
30. G Murphy A Murthy R Khokha 2008 Clipping, shedding and RIPping keep immunity on cue Trends Immunol 29 2 75 82
31. R Mentlein B Gallwitz WE Schmidt 1993 Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum Eur J Biochem 214 829 835
32. TJ Kieffer CH McIntosh RA Pederson 1995 Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV Endocrinology 136 8 3585 3596
33. CF Deacon AH Johnsen JJ Holst 1995 Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide that is a major endogenous metabolite in vivo J Clin Endocrinol Metab 80 3 952 957
34. L Hansen et al. 1999 Glucagon-like peptide-1-(7-36)amide is transformed to glucagon-like peptide-1-(9-36)amide by dipeptidyl peptidase IV in the capillaries supplying the L cells of the porcine intestine Endocrinology 140 11 5356 5363
35. LA Nikolaidis et al. 2005 Active metabolite of GLP-1 mediates myocardial glucose uptake and improves left ventricular performance in conscious dogs with dilated cardiomyopathy Am J Physiol Heart Circ Physiol 289 6 H2401 H2408
36. PB Jeppesen et al. 2005 Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients Gut 54 9 1224 1231
37. CF Deacon et al. 2000 Degradation of endogenous and exogenous gastric inhibitory polypeptide in healthy and in type 2 diabetic subjects as revealed using a new assay for the intact peptide J Clin Endocrinol Metab 85 10 3575 3581
38. CF Deacon et al. 2001 Dipeptidyl peptidase IV inhibition reduces the degradation and clearance of GIP and potentiates its insulinotropic and antihyperglycemic effects in anesthetized pigs Diabetes 50 7 1588 1597
39. JA Pospisilik et al. 2001 Metabolism of glucagon by dipeptidyl peptidase IV (CD26) Regul Pept 96 3 133 141
40. SA Hinke et al. 2000 Dipeptidyl peptidase IV (DPIV/CD26) degradation of glucagon. Characterization of glucagon degradation products and DPIV-resistant analogs J Biol Chem 275 6 3827 3834
41. AM Lambeir et al. 2001 Kinetic study of the processing by dipeptidyl-peptidase IV/CD26 of neuropeptides involved in pancreatic insulin secretion FEBS Lett 507 3 327 330
42. JR Reeve Jr 1983 Amino acid sequences of three bombesin-like peptides from canine intestine extracts J Biol Chem 258 9 5582 5588
43. GH Ballantyne 2006 Peptide YY(1-36) and peptide YY(3-36). Part II. Changes after gastrointestinal surgery and bariatric surgery Obes Surg 16 6 795 803
44. GH Ballantyne 2006 Peptide YY(1-36) and peptide YY(3-36). Part I. Distribution, release and actions Obes Surg 16 5 651 658
45. EK Jackson JH Dubinion Z Mi 2008 Effects of dipeptidyl peptidase IV inhibition on arterial blood pressure Clin Exp Pharmacol Physiol 35 1 29 34
46. MD Medeiros AJ Turner 1994 Processing and metabolism of peptide-YY: pivotal roles of dipeptidylpeptidase-IV, aminopeptidase-P, and endopeptidase-24.11 Endocrinology 134 5 2088 2094
47. R Mentlein 1999 Dipeptidyl-peptidase IV (CD26)-role in the inactivation of regulatory peptides Regul Pept 85 1 9 24
48. JB Byrd et al. 2008 Dipeptidyl peptidase IV in angiotensin-converting enzyme inhibitor associated angioedema Hypertension 51 1 141 147
49. RM Fryer et al. 2008 Effect of bradykinin metabolism inhibitors on evoked hypotension in rats: rank efficacy of enzymes associated with bradykinin-mediated angioedema Br J Pharmacol 153 5 947 955
50. JB Pesquero et al. 1992 Bradykinin metabolism pathway in the rat pulmonary circulation J Hypertens 10 12 1471 1478
51. R Mentlein T Roos 1996 Proteases involved in the metabolism of angiotensin II, bradykinin, calcitonin gene-related peptide (CGRP), and neuropeptide Y by vascular smooth muscle cells Peptides 17 4 709 720
52. I Brandt et al. 2006 Dipeptidyl-peptidase IV converts intact B-type natriuretic peptide into its des-SerPro form Clin Chem 52 1 82 87
53. M Vanderheyden 2008 Clinical importance of BNP truncation by DPPIV Clin Chem Lab Med 46 4 A18
54. K Abe JU Tilan Z Zukowska 2007 NPY and NPY receptors in vascular remodeling Curr Top Med Chem 7 17 1704 1709
55. LE Kuo et al. 2007 Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome Nat Med 13 7 803 811
56. J Kitlinska et al. 2005 Differential effects of neuropeptide Y on the growth and vascularization of neural crest-derived tumors Cancer Res 65 5 1719 1728
57. B Jarmołowska et al. 2007 Serum activity of dipeptidyl peptidase IV (DPPIV; EC 3.4.14.5) in breast-fed infants with symptoms of allergy Peptides 28 3 678 682
58. C Tiruppathi et al. 1990 Hydrolysis and transport of proline-containing peptides in renal brush-border membrane vesicles from dipeptidyl peptidase IV-positive and dipeptidyl peptidase IV-negative rat strains J Biol Chem 256 3 1476 1483
59. R Guieu et al. 2006 CD26 modulates nociception in mice via its dipeptidyl-peptidase IV activity Behav Brain Res 166 2 230 235
60. Z Bagosi et al. 2006 The effects of endomorphins and diprotin A on striatal dopamine release induced by electrical stimulation-an in vitro superfusion study in rats Neurochem Int 49 7 665 668
61. T Karl et al. 2003 Extreme reduction of dipeptidyl peptidase IV activity in F344 rat substrains is associated with various behavioral differences Physiol Behav 80 1 123 134
62. E Grouzmann et al. 2002 Loss of dipeptidylpeptidase IV activity in chronic rhino sinusitis contributes to the neurogenic inflammation induced by substance P in the nasal mucosa FASEB J 16 9 1132 1134
63. P Busek et al. 2008 Modulation of substance P signaling by dipeptidyl peptidase-IV enzymatic activity in human glioma cell lines Physiol Res 57 3 443 449
64. P Proost et al. 2000 Cleavage by CD26/dipeptidyl peptidase IV converts the chemokine LD78beta into a most efficient monocyte attractant and CCR1 agonist Blood 96 5 1674 1680
65. S Struyf et al. 2001 Diverging binding capacities of natural LD78beta isoforms of macrophage inflammatory protein-1alpha to the CC chemokine receptors 1, 3 and 5 affect their anti-HIV-1 activity and chemotactic potencies for neutrophils and eosinophils Eur J Immunol 31 7 2170 2178
66. E Guan J Wang MA Norcross 2004 Amino-terminal processing of MIP-1beta/CCL4 by CD26/dipeptidyl-peptidase IV J Cell Biochem 92 1 53 64
67. TB Campbell HE Broxmeyer 2008 CD26 inhibition and hematopoiesis: a novel approach to enhance transplantation Front Biosci 13 1795 1805
68. T Oravecz et al. 1997 Regulation of the receptor specificity and function of the chemokine RANTES (regulated on activation, normal T cell expressed and secreted) by dipeptidyl peptidase IV (CD26)-mediated cleavage J Exp Med 186 11 1865 1872
69. D Schols et al. 1998 CD26-processed RANTES(3-68), but not intact RANTES, has potent anti-HIV-1 activity Antiviral Res 39 3 175 187
70. P Proost et al. 1998 Amino-terminal truncation of chemokines by CD26/dipeptidyl-peptidase IV. Conversion of RANTES into a potent inhibitor of monocyte chemotaxis and HIV-1-infection J Biol Chem 273 13 7222 7227
71. S Struyf et al. 1999 CD26/dipeptidyl-peptidase IV downregulates the eosinophil chemotactic potency, but not the anti-HIV activity of human eotaxin by affecting its interaction with CC chemokine receptor 3 J Immunol 162 8 4903 4909
72. U Forssmann et al. 2008 Inhibition of CD26/dipeptidyl peptidase IV enhances CCL11/eotaxin-mediated recruitment of eosinophils in vivo J Immunol 181 2 1120 1127
73. P Proost et al. 1999 Truncation of macrophage-derived chemokine by CD26/dipeptidyl-peptidase IV beyond its predicted cleavage site affects chemotactic activity and CC chemokine receptor 4 interaction J Biol Chem 274 7 3988 3993
74. P Proost et al. 2001 Amino-terminal truncation of CXCR3 agonists impairs receptor signaling and lymphocyte chemotaxis, while preserving antiangiogenic properties Blood 98 13 3554 3561
75. P Proost et al. 2006 Natural posttranslational modifications of chemokines Biochem Soc Trans 34 6 997 1001
76. P Proost et al. 2006 Coexpression and interaction of CXCL10 and CD26 in mesenchymal cells by synergising inflammatory cytokines: CXCL8 and CXCL10 are discriminative markers for autoimmune arthropathies Arthritis Res Ther 8 4 R107
77. A Ludwig et al. 2002 Dipeptidyl peptidase IV (CD26) on T cells cleaves the CXC chemokine CXCL11 (I-TAC) and abolishes the stimulating but not the desensitizing potential of the chemokine J Leukoc Biol 72 1 183 191
78. P Proost et al. 2007 Proteolytic processing of CXCL11 by CD13/aminopeptidase N impairs CXCR3 and CXCR7 binding and signaling and reduces lymphocyte and endothelial cell migration Blood 110 1 37 44
79. T Ohtsuki et al. 1998 Negative regulation of the anti-human immunodeficiency virus and chemotactic activity of human stromal cell-derived factor 1alpha by CD26/dipeptidyl peptidase IV FEBS Lett 431 2 236 240
80. P Proost et al. 1998 Processing by CD26/dipeptidyl-peptidase IV reduces the chemotactic and anti-HIV-1 activity of stromal-cell derived factor-1alpha FEBS Lett 432 1-2 73 76
81. T Shioda et al. 1998 Anti-HIV-1 and chemotactic activities of human stromal cell-derived factor 1alpha (SDF-1alpha) and SDF-1beta are abolished by CD26/dipeptidyl peptidase IV-mediated cleavage Proc Natl Acad Sci USA 95 11 6331 6336
82. S Struyf et al. 2003 Regulation of the immune response by the interaction of chemokines and proteases Adv Immunol 81 1 44
83. YX Sun et al. 2008 CD26/dipeptidyl peptidase IV regulates prostate cancer metastasis by degrading SDF-1/CXCL12 Clin Exp Metastasis 25 7 765 776
84. I Nausch et al. 1990 The degradation of bioactive peptides and proteins by dipeptidyl peptidase IV from human placenta Biol Chem Hoppe Seyler 371 11 1113 1118
85. T Kahne et al. 1999 Dipeptidyl peptidase IV: a cell surface peptidase involved in regulating T cell growth Int J Mol Med 4 1 3 15
86. A Banbula et al. 2000 Emerging family of proline-specific peptidases of Porphyromonas gingivalis: purification and characterization of serine dipeptidyl peptidase, a structural and functional homologue of mammalian prolyl dipeptidyl peptidase IV Infect Immun 68 3 1176 1182
87. D Reinhold et al. 2007 Dual inhibition of dipeptidyl peptidase IV and aminopeptidase N suppresses inflammatory immune responses Ann N Y Acad Sci 1110 402 409
88. D Reinhold et al. 2008 DP IV/CD26, APN/CD13 and related enzymes as regulators of T cell immunity: implications for experimental encephalomyelitis and multiple sclerosis Front Biosci 13 2356 2363
89. M Wolf S Albrecht C Märki 2008 Proteolytic processing of chemokines: implications in physiological and pathological conditions Int J Biochem Cell Biol 40 6-7 1185 1198
90. WA Weihofen et al. 2004 Crystal structure of CD26/dipeptidyl-peptidase IV in complex with adenosine deaminase reveals a highly amphiphilic interface J Biol Chem 279 41 43330 43335
91. K Aertgeerts et al. 2004 N-linked glycosylation of dipeptidyl peptidase IV (CD26): effects on enzyme activity, homodimer formation, and adenosine deaminase binding Protein Sci 13 1 145 154
92. M Cuchacovich et al. 2001 Characterization of human serum dipeptidyl peptidase IV (CD26) and analysis of its autoantibodies in patients with rheumatoid arthritis and other autoimmune diseases Clin Exp Rheumatol 19 6 673 680
93. KW Christopherson II et al. 2004 Modulation of hematopoietic stem cell homing and engraftment by CD26 Science 305 5686 1000 1003
94. A Thielitz et al. 2008 The ectopeptidases dipeptidyl peptidase IV (DP IV) and aminopeptidase N (APN) and their related enzymes as possible targets in the treatment of skin diseases Front Biosci 13 2364 2375
95. K Narra et al. 2007 Phase II trial of single agent Val-boroPro (Talabostat) inhibiting Fibroblast Activation Protein in patients with metastatic colorectal cancer Cancer Biol Ther 6 11 1691 1699
96. LL Baggio DJ Drucker 2007 Biology of incretins: GLP-1 and GIP Gastroenterology 132 6 2131 2157
97. DJ Drucker MA Nauck 2006 The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes Lancet 368 9548 1696 1705
98. LL Baggio DJ Drucker 2006 Therapeutic approaches to preserve islet mass in type 2 diabetes Annu Rev Med 57 265 281
99. WN Dinjens et al. 1989 Distribution of adenosine deaminase-complexing protein in murine tissues J Biol Chem 264 32 19215 19220
100. CF Deacon et al. 1995 Both subcutaneously and intravenously administered glucagon-like peptide 1 are rapidly degraded from the NH2-terminus in type II diabetic patients and in healthy subjects Diabetes 44 9 1126 1131
101. GR Lankas et al. 2005 Dipeptidyl peptidase IV inhibition for the treatment of type 2 diabetes: potential importance of selectivity over dipeptidyl peptidases 8 and 9 Diabetes 54 10 2988 2994
102. YJ Chyan LM Chuang 2007 Dipeptidyl peptidase IV inhibitors: an evolving treatment for type 2 diabetes from the incretin concept. Recent patents on endocrine Metab Immune Drug Discov 1 15 24
103. RE Amori J Lau AG Pittas 2007 Efficacy and safety of incretin therapy in type 2 diabetes: systematic review and meta-analysis JAMA 298 2 194 206
104. E Grouzmann et al. 2007 Adverse effects of incretin therapy for type 2 diabetes JAMA 298 15 1759 1760 author reply 1760
105. PP Trotta ME Balis 1978 Characterization of adenosine deaminase from normal coton and colon tumors. Evidence for tumor specific variants Biochemistry 77 2 270 277
106. J Ten Kate et al. 1984 Quantitative changes in adenosine deaminase isoenzymes in human colorectal adenocarcinomas Cancer Res 44 10 4688 4692
107. J Ten Kate et al. 1985 Immunohistochemical localization of adenosine deaminase complexing protein in intestinal mucosa and in colorectal adenocarcinoma as a marker for tumour cell heterogeneity Histochem J 17 1 23 31
108. J Ten Kate et al. 1986 Adenosine deaminase complexing protein (ADCP) immunoreactivity in colorectal adenocarcinoma Int J Cancer 37 4 479 485
109. J Ten Kate et al. 1986 Adenosine deaminase complexing protein in cancer studies Anticancer Res 6 5 983 988
110. WN Dinjens 1990 Adenosine deaminase complexing protein (ADCP) expression and metastatic potential in prostatic adenocarcinomas J Pathol 160 3 195 201
111. M Martín et al. 1995 Expression of ecto-adenosine deaminase and CD26 in human T cells triggered by the TCR-CD3 complex. Possible role of adenosine deaminase as costimulatory molecule J Immunol 155 10 4630 4643
112. OJ Cordero et al. 2001 Cytokines regulate membrane adenosine deaminase on human activated lymphocytes J Leukoc Biol 70 6 920 930
113. C Herrera et al. 2001 Adenosine A2B receptors behave as an alternative anchoring protein for cell surface adenosine deaminase in lymphocytes and cultured cells Mol Pharmacol 59 1 127 134
114. T Hashikawa et al. 2004 Regulation of adenosine receptor engagement by ecto-adenosine deaminase FASEB J 18 1 131 133
115. S Ginés et al. 2002 Regulation of epithelial and lymphocyte cell adhesion by adenosine deaminase-CD26 interaction Biochem J 361 2 203 209
116. S Iwata C Morimoto 1999 CD26/dipeptidyl peptidase IV in context. The different roles of a multifunctional ectoenzyme in malignant transformation J Exp Med 190 3 301 306
117. D Lukashev A Ohta M Sitkovsky 2007 Hypoxia-dependent anti-inflammatory pathways in protection of cancerous tissues Cancer Metastasis Rev 26 2 273 279
118. DW Hoskin et al. 2008 Inhibition of T cell and natural killer cell function by adenosine and its contribution to immune evasion by tumor cells Int J Oncol 32 3 527 535
119. N White G Burnstock 2006 P2 receptors and cancer Trends Pharmacol Sci 27 4 211 217
120. M Gonzalez-Gronow et al. 2008 Dipeptidyl peptidase IV (DPP IV/CD26) is a cell-surface plasminogen receptor Front Biosci 13 1610 1618
121. PA Havre et al. 2008 The role of CD26/dipeptidyl peptidase IV in cancer Front Biosci 13 1634 1645
122. A Sedo E Krepela E Kasafírek 1991 Dipeptidyl peptidase IV, prolyl endopeptidase and cathepsin B activities in primary human lung tumors and lung parenchyma J Cancer Res Clin Oncol 117 3 249 253
123. Y Asada et al. 1993 Expression of dipeptidyl aminopeptidase IV activity in human lung carcinoma Histopathology 23 3 265 270
124. E Krepela et al. 1996 Lysosomal dipeptidyl-peptidases I and II in human squamous cell lung carcinoma and lung parenchyma Neoplasma 43 3 171 178
125. JE Park et al. 1999 Fibroblast activation protein, a dual specificity serine protease expressed in reactive human tumor stromal fibroblasts J Biol Chem 274 51 36505 36512
126. J Davoodi et al. 2007 The Simpson-Golabi-Behmel syndrome causative glypican-3, binds to and inhibits the dipeptidyl peptidase activity of CD26 Proteomics 7 13 2300 2310
127. D Baumhoer et al. 2008 Glypican 3 expression in human nonneoplastic, preneoplastic, and neoplastic tissues: a tissue microarray analysis of 4,387 tissue samples Am J Clin Pathol 129 6 899 906
128. W Cheng et al. 2008 Glypican-3-mediated oncogenesis involves the insulin-like growth factor-signaling pathway Carcinogenesis 29 7 1319 1326
129. BD Jakubovic S Jothy 2007 Glypican-3: from the mutations of Simpson-Golabi-Behmel genetic syndrome to a tumor marker for hepatocellular carcinoma Exp Mol Pathol 82 2 184 189
130. P O'Brien BF O'Connor 2008 Seprase: an overview of an important matrix serine protease Biochim Biophys Acta 1784 9 1130 1145
131. E Ostermann et al. 2008 Effective immunoconjugate therapy in cancer models targeting a serine protease of tumor fibroblasts Clin Cancer Res 14 14 4584 4592
132. MA Huber et al. 2003 Fibroblast activation protein: differential expression and serine protease activity in reactive stromal fibroblasts of melanocytic skin tumors J Invest Dermatol 120 2 182 188
133. MA Goscinski et al. 2008 Seprase, dipeptidyl peptidase IV and Urokinase-type plasminogen activator expression in dysplasia and invasive squamous cell carcinoma of the esophagus. A study of 229 cases from Anyang Tumor Hospital, Henan Province, China Oncology 75 1-2 49 59
134. Z Werb 1997 ECM and cell surface proteolysis: regulating cellular ecology Cell 91 4 439 442
135. GA Piazza et al. 1989 Evidence for a role of dipeptidyl peptidase IV in fibronectin-mediated interactions of hepatocytes with extracellular matrix Biochem J 262 1 327 334
136. MJ Scanlan et al. 1994 Molecular cloning of fibroblast activation protein alpha, a member of the serine protease family selectively expressed in stromal fibroblasts of epithelial cancers Proc Natl Acad Sci USA 91 12 5657 5661
137. JB Sneddon Z Werb 2007 Location, location, location: the cancer stem cell niche Cell Stem Cell 1 6 607 611
138. P Ruiz et al. 1998 CD26 expression and dipeptidyl peptidase IV activity in an aggressive hepatosplenic T-cell lymphoma Cytometry 34 1 30 35
139. NH Dang et al. 2003 T-large granular lymphocyte lymphoproliferative disorder: expression of CD26 as a marker of clinically aggressive disease and characterization of marrow inhibition Br J Haematol 121 5 857 865
140. A Carbone et al. 1995 The expression of CD26 and CD40 ligand is mutually exclusive in human T-cell non-Hodgkins-lymphomas leukemias Blood 86 12 4617 4626
141. B Bauvois et al. 1999 Constitutive expression of CD26/dipeptidylpeptidase IV on peripheral blood B lymphocytes of patients with B chronic lymphocytic leukaemia Br J Cancer 79 7-8 1042 1048
142. K Hirai et al. 1999 Dipeptidyl peptidase IV (DPP IV/CD26) staining predicts distant metastasis of 'benign' thyroid tumor Pathol Int 49 3 264 265
143. C de Micco et al. 2008 Utility of malignancy markers in fine-needle aspiration cytology of thyroid nodules: comparison of Hector Battifora mesothelial antigen-1, thyroid peroxidase and dipeptidyl aminopeptidase IV Br J Cancer 98 4 818 823
144. J Stremenova et al. 2007 Expression and enzymatic activity of dipeptidyl peptidase-IV in human astrocytic tumours are associated with tumour grade Int J Oncol 31 4 785 792
145. U Yamaguchi et al. 2008 Distinct gene expression-defined classes of gastrointestinal stromal tumor J Clin Oncol 26 25 4100 4108
146. Cro L et al (2009) CD26 expression in mature B-cell neoplasia: its possible role as a new prognostic marker in B-CLL. Hematol Oncol Feb 26 on-line
147. Carlucci F et al (2009) A 57-gene expression signature in B-cell chronic lymphocytic leukemia. Biomed Pharmacother. doi: 10.1016/j.biopha.2009.02.001
148. MJ Wilson et al. 2005 Elevation of dipeptidylpeptidase IV activities in the prostate peripheral zone and prostatic secretions of men with prostate cancer: possible prostate cancer disease marker J Urol 74 3 1124 1128
149. A Sedo E Krepela E Kasafirek 1991 Dipeptidyl peptidase IV, prolyl endopeptidase and cathepsin B activities in primary human lung tumors and lung parenchyma J Cancer Res Clin Oncol 117 3 249 253
150. J Kojima et al. 1987 Glycylproline dipeptidyl aminopeptidase and gamma-glutamyl-transferase transpeptidase in human hepatic cancer and embryonal tissues Clin Chim Acta 167 3 285 291
151. MC Moehrle et al. 1995 Aminopeptidase-M and dipeptidyl peptidase-IV activity in epithelial skin tumors-a histochemical-study J Cutan Pathol 22 3 241 247
152. A Roesch et al. 2006 Loss of dipeptidyl peptidase IV immunostaining discriminates malignant melanomas from deep penetrating nevi Mod Pathol 19 10 1378 1385
153. T Inamoto et al. 2007 Humanized anti-CD26 monoclonal antibody as a treatment for malignant mesothelioma tumors Clin Cancer Res 13 14 4191 4200
154. T Inamoto et al. 2006 Anti-CD26 monoclonal antibody-mediated G1-S arrest of human renal clear cell carcinoma Caki-2 is associated with retinoblastoma substrate dephosphorylation, cyclin-dependent kinase 2 reduction, p27(kip1) enhancement, and disruption of binding to the extracellular matrix Clin Cancer Res 12 11 Pt1 3470 3477
155. S Verstovsek F Cabanillas NH Dang 2000 CD26 in T-cell lymphomas: a potential clinical role? Oncology (Huntingt) 14 6 Suppl 2 17 23
156. D Jones et al. 2001 Absence of CD26 expression is a useful marker for diagnosis of T-cell lymphoma in peripheral blood Am J Clin Pathol 115 6 885 892
157. MG Bernengo et al. 2001 The relevance of the CD4+ CD26- subset in the identification of circulating Sézary cells Br J Dermatol 144 1 125 135
158. S Kondo et al. 1996 Expression of CD26/dipeptidyl peptidase IV in adult T cell leukemia/lymphoma (ATLL) Leuk Res 20 4 357 363
159. JJ Van den Oord 1998 Expression of CD26/dipeptidyl-peptidase IV in benign and malignant pigment-cell lesions of the skin Br J Dermatol 138 4 615 621
160. EE Khin et al. 2003 Dipeptidyl peptidase IV expression in endometrial endometrioid adenocarcinoma and its inverse correlation with tumor grade Am J Obstet Gynecol 188 3 670 676
161. H Kajiyama et al. 2003 Expression of CD26/dipeptidyl peptidase IV in endometrial adenocarcinoma and its negative correlation with tumor grade Adv Exp Med Biol 524 245 248
162. T Bogenrieder et al. 1997 Expression and localization of aminopeptidase A, aminopeptidase N, and dipeptidyl peptidase IV in benign and malignant human prostate tissue Prostate 33 4 225 232
163. AN Houghton et al. 1988 Cell surface antigens of human melanocytes and melanoma. Expression of adenosine deaminase binding protein is extinguished with melanocyte transformation J Exp Med 167 1 197 212
164. ME Morrison et al. 1993 A marker for neoplastic progression of human melanocytes is a cell surface ectopeptidase J Exp Med 177 4 1135 1143
165. AP Albino et al. 1992 Malignant transformation of human melanocytes: induction of a complete melanoma phenotype and genotype Oncogene 7 11 2315 2321
166. UV Wesley et al. 1999 A role for dipeptidyl peptidase IV in suppressing the malignant phenotype of melanocytic cells J Exp Med 190 3 311 322
167. UV Wesley et al. 2004 Role for dipeptidyl peptidase IV in tumor suppression of human non small cell lung carcinoma cells Int J Cancer 109 6 855 866
168. UV Wesley M McGroarty A Homoyouni 2005 Dipeptidyl peptidase inhibits malignant phenotype of prostate cancer cells by blocking basic fibroblast growth factor signaling pathway Cancer Res 65 4 1325 1334
169. H Kajiyama et al. 2002 Prolonged survival and decreased invasive activity attributable to dipeptidyl peptidase IV overexpression in ovarian carcinoma Cancer Res 62 10 2753 2757
170. F Kikkawa et al. 2005 Dipeptidyl peptidase IV in tumor progression Biochim Biophys Acta 1751 1 45 51
171. P Busek J Stremenova A Sedo 2008 Dipeptidyl peptidase-IV enzymatic activity bearing molecules in human brain tumors-good or evil? Front Biosci 13 2319 2326
172. V Preller et al. 2007 TGF-beta1-mediated control of central nervous system inflammation and autoimmunity through the inhibitory receptor CD26 J Immunol 178 7 4632 4640
173. LM Coussens Z Werb 2002 Inflammation and cancer Nature 420 6917 860 867
174. GA Rabinovich D Gabrilovich EM Sotomayor 2007 Immunosuppressive strategies that are mediated by tumor cells Annu Rev Immunol 25 267 296
175. A Steinbrecher et al. 2001 Targeting dipeptidyl peptidase IV (CD26) suppresses autoimmune encephalomyelitis and up-regulates TGF-beta 1 secretion in vivo J Immunol 166 3 2041 2048
176. K Shingu et al. 2003 CD26 expression determines lung metastasis in mutant F344 rats: involvement of NK cell function and soluble CD26 Cancer Immunol Immunother 52 9 546 554
177. I Nagatsu T Nagatsu T Yamamoto 1968 Hydrolysis of amino acid beta-naphthylamides by aminopeptidases in human parotid salva and human serum Experientia 24 4 347 348
178. RE Smith et al. 1998 The significance of hypersialylation of dipeptidyl peptidase IV (CD26) in the inhibition of its activity by Tat and other cationic peptides. CD26: a subvertid adhesion molecule for HIV peptide binding AIDS Res Hum Retroviruses 14 10 851 868
179. G Blanc et al. 2007 Insights into how CUB domains can exert specific functions while sharing a common fold: conserved and specific features of the CUB1 domain contribute to the molecular basis of procollagen C-proteinase enhancer-1 activity J Biol Chem 282 23 16924 16933
180. C Wermter et al. 2007 The protease domain of procollagen C-proteinase (BMP1) lacks substrate selectivity, which is conferred by non-proteolytic domains Biol Chem 388 5 513 521
181. TM Gunn et al. 1999 The mouse mahogany locus encodes a transmembrane form of human attractin Nature 398 6723 152 156
182. JS Duke-Cohan et al. 1995 A novel form of dipeptidylpeptidase IV found in human serum. Isolation, characterization, and comparison with T lymphocyte membrane dipeptidylpeptidase IV (CD26) J Biol Chem 270 23 14107 14114
183. JS Duke-Cohan et al. 1996 Serum high molecular weight dipeptidyl peptidase IV (CD26) is similar to a novel antigen DPPT-L released from activated T cells J Immunol 156 5 1714 1721
184. D Friedrich et al. 2007 Does human attractin have DP4 activity? Biol Chem 388 2 155 162
185. W Tang et al. 2000 Secreted and membrane attractin result from alternative splicing of the human ATRN gene Proc Natl Acad Sci USA 97 11 6025 6030
186. WP Schrader FJ Woodward B Pollara 1979 Purification of an adenosine deaminase complexing protein from human plasma J Biol Chem 254 23 11964 11968
187. S Iwaki-Egawa et al. 1998 Dipeptidyl peptidase IV from human serum: purification, characterization, and N-terminal amino acid sequence J Biochem (Tokyo) 124 2 428 433
188. C Durinx et al. 2000 Molecular characterization of dipeptidyl peptidase activity in serum. Soluble CD26/dipeptidyl peptidase IV is responsible for the release of X-Pro dipeptides Eur J Biochem 267 17 5608 5613
189. Y Watanabe et al. 1998 Aminopeptidase N in sera of healthy subjects is a different N-terminal processed derivative from the one obtained from maternal serum Mol Genet Metab 63 4 289 294
190. Y Watanabe et al. 1995 Identification of an alanine aminopeptidase in human maternal serum as a membrane-bound aminopeptidase N Biol Chem Hoppe Seyler 376 7 397 400
191. NM Hooper EH Karran AJ Turner 1997 Membrane protein secretases Biochem J 321 2 265 279
192. B Bauvois et al. 2000 Regulation of CD26/DPPIV gene expression by interferons and retinoic acid in tumor B cells Oncogene 19 2 265 272
193. J Schade et al. 2008 Regulation of expression and function of dipeptidyl peptidase 4 (DP4), DP8/9, and DP10 in allergic responses of the lung in rats J Histochem Cytochem 56 2 147 155
194. EM Danielsen GM Cowell SS Poulsen 1983 Biosynthesis of intestinal microvillar proteins. Role of the Golgi complex and microtubules Biochem J 216 1 37 42
195. J Arribas et al. 1996 Diverse cell surface protein ectodomains are shed by a system sensitive to metalloprotease inhibitors J Biol Chem 271 19 11376 11382
196. MK Lemberg M Freeman 2007 Cutting proteins within lipid bilayers: rhomboid structure and mechanism Mol Cell 28 6 930 940
197. G Grondin NM Hooper D LeBel 1999 Specific localization of membrane dipeptidase and dipeptidyl peptidase IV in secretion granules of two different pancreatic islet cells J Histochem Cytochem 47 4 489 498
198. MD Poulsen et al. 1993 Dipeptidyl peptidase IV is sorted to the secretory granules in pancreatic islet A-cells J Histochem Cytochem 41 1 81 88
199. DC Macnair AJ Kenny 1979 Proteins of the kidney microvillar membrane. The amphipathic form of dipeptidyl peptidase IV Biochem J 179 2 379 395
200. SK Böhm et al. 1995 Human dipeptidyl peptidase IV gene promoter: tissue-specific regulation from a TATA-less GC-rich sequence characteristic of a housekeeping gene promoter Biochem J 311 3 835 843
201. TK Teague et al. 1999 Activation changes the spectrum but not the diversity of genes expressed by T cells Proc Natl Acad Sci USA 96 22 12691 12696
202. L Rogge et al. 2000 Transcript imaging of the development of human T helper cells using oligonucleotide arrays Nat Genet 25 1 96 101
203. T Mattern et al. 1995 Antibody-induced modulation of CD26 surface expression Immunology 84 4 60 595
204. FJ Salgado et al. 2000 Mechanisms of CD26/dipeptidyl peptidase IV cytokine-dependent regulation on human activated lymphocytes Cytokine 12 7 1136 1141
205. I Beau A Berger AL Servin 2007 Rotavirus impairs the biosynthesis of brush-border-associated dipeptidyl peptidase IV in human enterocyte-like Caco-2/TC7 cells Cell Microbiol 9 3 779 789
206. T Hama et al. 1982 Purification of dipeptidyl-aminopeptidase IV from human kidney by anti dipeptidyl-aminopeptidase IV affinity chromatography Mol Cell Biochem 43 1 35 42
207. E Krepela et al. 1983 Demonstration of two molecular forms of dipeptidyl peptidase IV in normal human serum Physiol Bohemoslov 32 6 486 496
208. C Théry L Zitvogel S Amigorena 2002 Exosomes: composition, biogenesis and function Nat Rev Immunol 2 8 569 579
209. G Mignot et al. 2006 Prospects for exosomes in immunotherapy of cancer J Cell Mol Med 10 2 376 388
210. JS Schorey S Bhatnagar 2008 Exosome function: from tumor immunology to pathogen biology Traffic 9 6 871 881
211. JL Gatti et al. 2005 Identification, proteomic profiling, and origin of ram epididymal fluid exosome-like vesicles Biol Reprod 72 6 1452 1465
212. J Mallegol G van Niel M Heyman 2005 Phenotypic and functional characterization of intestinal epithelial exosomes Blood Cells Mol Dis 35 1 11 16
213. Y Ogawa et al. 2008 Exosome-like vesicles with dipeptidyl peptidase IV in human saliva Biol Pharm Bull 31 6 1059 1062
214. N Busso et al. 2005 Circulating CD26 is negatively associated with inflammation in human and experimental arthritis Am J Pathol 166 2 433 442
215. MG Narducci et al. 2006 Skin homing of Sezary cells involves SDF-1-CXCR4 signaling and down-regulation of CD26/dipeptidylpeptidase IV Blood 107 3 1108 1115
216. S Iwaki-Egawa Y Watanabe Y Fujimoto 1995 Is CD26/dipeptidyl peptidase IV a really important molecule in T cell activation of a certain rat strain? Immunobiology 194 4-5 429 442
217. D Marguet et al. 2000 Enhanced insulin secretion and improved glucose tolerance in mice lacking CD26 Proc Natl Acad Sci USA 97 12 6874 6879
218. S Yan et al. 2003 Deficiency of CD26 results in a change of cytokine and immunoglobulin secretion after stimulation by pokeweed mitogen Eur J Immunol 33 6 1519 1527
219. T Nagatsu T Sakai K Kojima 1985 A sensitive and specific assay for dipeptidyl-aminopeptidase II in serum and tissues by liquid chromatography- fluorometry Anal Biochem 147 1 80 85
220. K Kojima R Mihara T Sakai 1987 Serum activities of dipeptidyl- aminopeptidase II and dipeptidyl-aminopeptidase IV in tumor-bearing animals and in cancer patients Biochem Med Metab Biol 37 1 35 41
221. MB Maes S Scharpé I De Meester 2007 Dipeptidyl peptidase II (DPPII), a review Clin Chim Acta 380 1-2 31 49
222. JS Rosenblum JW Kozarich 2003 Prolyl peptidases: a serine protease subfamily with high potential for drug discovery Curr Opin Chem Biol 7 4 496 504
223. MB Maes et al. 2005 Kinetic investigation of human dipeptidyl peptidase II (DPPII)-mediated hydrolysis of dipeptide derivatives and its identification as quiescent cell proline dipeptidase (QPP)/dipeptidyl peptidase 7 (DPP7) Biochem J 386 2 315 324
224. H Araki et al. 2001 Purification, molecular cloning, and immunohistochemical localization of dipeptidyl peptidase II from the rat kidney and its identity with quiescent cell proline dipeptidase J Biochem 129 2 279 288
225. R Underwood et al. 1999 Sequence, purification, and cloning of an intracellular serine protease, quiescent cell proline dipeptidase J Biol Chem 274 48 34053 34058
226. M Chiravuri et al. 2000 Vesicular localization and characterization of a novel post-proline-cleaving aminodipeptidase, quiescent cell proline dipeptidase J Immunol 165 10 5695 5702
227. M Chiravuri et al. 2000 Homodimerization via a leucine zipper motif is required for enzymatic activity of quiescent cell proline dipeptidase J Biol Chem 275 35 26994 26999
228. M Chiravuri BT Huber 2000 Aminodipeptidase inhibitor-induced cell death in quiescent lymphocytes: a review Apoptosis 5 4 319 322
229. MB Maes et al. 2006 Dipeptidyl peptidase II and leukocyte cell death Biochem Pharmacol 72 1 70 79
230. G Struckhoff E Heymann 1986 Rat peritoneal mast cells release dipeptidyl peptidase II Biochem J 236 1 215 219
231. P Klener et al. 1987 Possible prognostic significance of the assessment of dipeptidylpeptidase II in peripheral blood lymphocytes of patients with chronic lymphocytic leukemia Neoplasma 34 5 581 586
232. AV Danilov et al. 2005 Differential control of G0 programme in chronic lymphocytic leukaemia: a novel prognostic factor Br J Haematol 128 4 472 481
233. M Urade et al. 1989 Serum dipeptidyl peptidase activities as a possible marker of oral cancer Cancer 64 6 1274 1280
234. M Mogi et al. 1986 Sandwich enzyme-immunoassay for dipeptidyl aminopeptidase IV in the serum of people with oral cancer Arch Oral Biol 31 7 505 507
235. KN Lee et al. 2004 A novel plasma proteinase potentiates alpha2-antiplasmin inhibition of fibrin digestion Blood 103 10 3783 3788
236. KN Lee et al. 2006 Antiplasmin-cleaving enzyme is a soluble form of fibroblast activation protein Blood 107 4 1397 1404
237. VJ Christiansen et al. 2007 The effect of a single nucleotide polymorphism on human alpha 2-antiplasmin activity Blood 109 12 5286 5292
238. PJ Collins et al. 2004 Purification, identification and characterisation of seprase from bovine serum Int J Biochem Cell Biol 36 11 2320 2333
239. RT Aimes et al. 2003 Endothelial cell serine proteases expressed during vascular morphogenesis and angiogenesis Thromb Haemost 89 3 561 572
240. D Chen et al. 2006 Activation of EDTA-resistant gelatinases in malignant human tumors Cancer Res 66 20 9977 9985
241. OJ Cordero et al. 2000 Preoperative serum CD26 levels: diagnostic efficiency and predictive value for colorectal cancer Br J Cancer 83 9 1139 1146
242. D Ayude et al. 2004 Clinical interest of the combined use of serum CD26 and alpha-l-fucosidase in the early detection diagnosis of colorectal cancer Dis Markers 19 6 267 272
243. OJ Cordero et al. 2008 Validation of serum CD26 as a screening marker for colorectal cancer Clin Chem Lab Med 46 4 A23
244. OJ Cordero et al. 2008 How the measurements of a few serum markers can be combined to enhance their clinical values in the management of cancer Anticancer Res 28 4 2333 2341
245. J de la Haba-Rodríguez et al. 2002 Soluble dipeptidyl peptidase IV (CD-26) in serum of patients with colorectal carcinoma Neoplasma 49 5 307 311
246. OJ Cordero et al. 2001 Interleukin 12, interleukin 15, soluble CD26 and adenosine deaminase levels in the sera of rheumatoid arthritis patients Rheumatol Int 21 2 69 74
247. T Ellingsen et al. 2007 In active chronic rheumatoid arthritis, dipeptidyl peptidase IV density is increased on monocytes and CD4(+) T lymphocytes Scand J Immunol 66 4 451 457
248. M Cuchacovich et al. 2002 Streptokinase promotes development of dipeptidyl peptidase IV (CD26) autoantibodies after fibrinolytic therapy in myocardial infarction patients Clin Diagn Lab Immunol 9 6 1253 1259
249. H Kobayashi et al. 2002 Reduction of serum soluble CD26/dipeptidyl peptidase IV enzyme activity and its correlation with disease activity in systemic lupus erythematosus J Rheumatol 29 9 1858 1866
250. Z Tamaki et al. 2008 Serum levels of soluble CD26 in patients with scleroderma J Dermatol Sci 52 1 67 69
251. SW Lun et al. 2007 Increased expression of plasma and CD4+ T lymphocyte costimulatory molecule CD26 in adult patients with allergic asthma J Clin Immunol 27 4 430 437
252. N Katoh et al. 2000 Soluble CD30 is more relevant to disease activity of atopic dermatitis than soluble CD26 Clin Exp Immunol 121 2 187 192
253. U Schönermarck et al. 2000 Circulating cytokines and soluble CD23, CD26 and CD30 in ANCA-associated vasculitides Clin Exp Rheumatol 18 4 457 463
254. O Hosono et al. 1999 Decreased dipeptidyl peptidase IV enzyme activity of plasma soluble CD26 and its inverse correlation with HIV-1 RNA in HIV-1 infected individuals Clin Immunol 91 3 283 295
255. SS Yang et al. 2006 Changes of soluble CD26 and CD30 levels correlate with response to interferon plus ribavirin therapy in patients with chronic hepatitis C J Gastroenterol Hepatol 21 12 1789 1793
256. M Itou et al. 2008 Altered expression of glucagon-like peptide-1 and dipeptidyl peptidase IV in patients with HCV-related glucose intolerance J Gastroenterol Hepatol 23 2 244 251
257. S Ajdary et al. 2006 Soluble CD26/CD30 levels in visceral leishmaniasis: markers of disease activity Clin Exp Immunol 145 1 44 47
258. S Ajdary et al. 2007 Soluble CD26 and CD30 levels in patients with anthroponotic cutaneous leishmaniasis J Infect 55 1 75 78
259. C Durinx et al. 2001 Reference values for plasma dipeptidylpeptidase IV activity and their association with other laboratory parameters Clin Chem Lab Med 39 2 155 159
260. S Scharpé et al. 1988 Assay of dipeptidyl peptidase IV in serum by fluorometry of 4-methoxy-2-naphthylamine Clin Chem 34 11 2299 2301
261. M Hino et al. 1975 Glycylprolyl beta-naphthylamidase activity in human serum Clin Chim Acta 62 1 5 11
262. H Fuyamada et al. 1977 Serum glycylproline p-nitroanilidase activity in human hypertension Clin Chim Acta 74 2 177 181
263. K Fujita et al. 1977 Serum glycylproline p-nitroanilidase activity in blood cancers Clin Chim Acta 81 2 215 217
264. J Kojima et al. 1979 Serum glycylproline dipeptidyl aminopeptidase activity in human hepatic cancer Clin Chim Acta 93 2 181 187
265. Y Yoshii et al. 1981 Changes in serum dipeptidyl-aminopeptidase IV (glycylprolyl dipeptidyl-aminopeptidase) activity of patients with gastric carcinoma after surgical excision and the enzyme activity in the carcinoma tissue Biochem Med 25 3 276 282
266. K Kojima et al. 1987 Serum activities of dipeptidyl-aminopeptidase II and dipeptidyl-aminopeptidase IV in tumor-bearing animals and in cancer patients Biochem Med Metab Biol 37 1 35 41
267. K Fukasawa et al. 1982 Serum dipeptidyl peptidase (DPP) IV activities in oral cancer patients Int J Oral Surg 11 4 246 250
268. M Urade et al. 1989 Serum dipeptidyl peptidase activities as a possible marker of oral cancer Cancer 64 6 1274 1280
269. M Hagihara M Ohhashi T Nagatsu 1987 Activities of dipeptidyl peptidase II and dipeptidyl peptidase IV in mice with lupus erythematosus-like syndrome and in patients with lupus erythematosus and rheumatoid arthritis Clin Chem 33 8 1463 1465
270. H Gotoh et al. 1988 Activity of dipeptidyl peptidase IV and post-proline cleaving enzyme in sera from osteoporotic patients Clin Chem 34 12 2499 2501
271. M Stancíková et al. 1992 Dipeptidyl peptidase IV in patients with systemic lupus erythematosus Clin Exp Rheumatol 10 4 381 385
272. A Bergmann C Bohuon 2002 Decrease of serum dipeptidylpeptidase activity in severe sepsis patients: relationship to procalcitonin Clin Chim Acta 321 1-2 123 126
273. F Perner et al. 1999 Dipeptidyl peptidase activity of CD26 in serum and urine as a marker of cholestasis: experimental and clinical evidence J Lab Clin Med 134 1 56 67
274. T Andrieu et al. 2003 Similar increased serum dipeptidyl peptidase IV activity in chronic hepatitis C and other viral infections J Clin Virol 27 1 59 68
275. PL Lakatos et al. 1999 Elevated serum dipeptidyl peptidase IV (CD26, EC 3.4.14.5) activity in patients with primary biliary cirrhosis J Hepatol 30 4 740
276. YH Balaban et al. 2007 Dipeptidyl peptidase IV (DDP IV) in NASH patients Ann Hepatol 6 4 242 250
277. GS Meneilly et al. 2000 Effect of ageing and diabetes on glucose-dependent insulinotropic polypeptide and dipeptidyl peptidase IV responses to oral glucose Diabet Med 17 5 346 350
278. E Mannucci et al. 2005 Hyperglycaemia increases dipeptidyl peptidase IV activity in diabetes mellitus Diabetologia 48 6 1168 1172
279. M Hildebrandt et al. 2001 Dipeptidyl peptidase IV (DP IV, CD26) in patients with inflammatory bowel disease Scand J Gastroenterol 36 10 1067 1072
280. Q Xiao et al. 2000 Circulating levels of glucagon-like peptide-2 in human subjects with inflammatory bowel disease Am J Physiol Regul Integr Comp Physiol 278 4 R1057 R1063
281. M Rose et al. 2002 T-cell immune parameters and depression in patients with Crohn's disease J Clin Gastroenterol 34 1 40 48
282. VH van der Velden et al. 1999 Peptidase activities in serum and bronchoalveolar lavage fluid from allergic asthmatics-comparison with healthy non-smokers and smokers and effects of inhaled glucocorticoids Clin Exp Allergy 29 6 813 823
283. B Jarmołowska et al. 2007 Serum activity of dipeptidyl peptidase IV (DPPIV; EC 3.4.14.5) in breast-fed infants with symptoms of allergy Peptides 28 3 678 682
284. D Detel M Persić J Varljen 2007 Serum and intestinal dipeptidyl peptidase IV (DPP IV/CD26) activity in children with celiac disease J Pediatr Gastroenterol Nutr 45 1 65 70
285. M Maes et al. 1999 Lower activity of serum peptidases in abstinent alcohol-dependent patients Alcohol 17 1 1 6
286. M Maes et al. 1998 Effects of psychological stress on serum prolyl endopeptidase and dipeptidyl peptidase IV activity in humans: higher serum prolyl endopeptidase activity is related to stress-induced anxiety Psychoneuroendocrinology 23 5 485 495
287. M Maes et al. 1997 Lower serum dipeptidyl peptidase IV activity in treatment resistant major depression: relationships with immune-inflammatory markers Psychoneuroendocrinology 22 2 65 78
288. M Maes et al. 1996 Alterations in plasma dipeptidyl peptidase IV enzyme activity in depression and schizophrenia: effects of antidepressants and antipsychotic drugs Acta Psychiatr Scand 93 1 1 8
289. S Elgün A Keskinege H Kumbasar 1999 Dipeptidyl peptidase IV and adenosine deaminase activity decrease in depression Psychoneuroendocrinology 24 8 823 832
290. M Hildebrandt et al. 1999 Alterations in expression and in serum activity of dipeptidyl peptidase IV (DPP IV, CD26) in patients with hyporectic eating disorders Scand J Immunol 50 5 536 541
291. D van West et al. 2000 Lowered serum dipeptidyl peptidase IV activity in patients with anorexia and bulimia nervosa Eur Arch Psychiatry Clin Neurosci 250 2 86 92
292. P Vlahović et al. 2007 Elevated serum dipeptidyl peptidase IV activity in patients with chronic tonsillitis Ann Clin Biochem 44 1 70 74
293. HJ Gruss et al. 1997 Hodgkin's disease: a tumor with disturbed immunological pathways Immunol Today 18 4 156 163
294. T Chikuma et al. 1990 Purification and properties of dipeptidyl peptidase IV from human urine Biol Chem Hoppe Seyler 371 4 325 330
295. W Haacke G Küllertz A Barth 1986 Diagnostic value of the enzyme dipeptidyl peptidase IV (DP IV) in abdominal cancers Arch Geschwulstforsch 56 2 145 153
296. G Küllertz J Boigk 1986 Dipeptidyl peptidase IV activity in the serum and synovia of patients with rheumatoid arthritis Z Rheumatol 45 2 52 56
297. S Elgün et al. 1999 Serum dipeptidyl peptidase IV activity correlates with the T-cell CD26 antigen Clin Chem Lab Med 37 8 839 840
298. A Sedo K Hátle P Stolba 1985 Changes in dipeptidyl-peptidase IV activity in human serum in pathological conditions of the thyroid gland Cas Lek Cesk 124 51 1579 1581
299. E Krepela et al. 1983 An assay of dipeptidyl peptidase IV activity in human serum and serum of pregnant women with glycyl-l-proline-1-naphthylamide and other glycyl-l-proline-arylamides as substrates Physiol Bohemoslov 32 4 334 345
300. JR Bartles et al. 1991 Decreases in the relative concentrations of specific hepatocyte plasma membrane proteins during liver regeneration: down-regulation or dilution? Dev Biol 143 2 258 270
301. JR Bartles et al. 1991 Expression and compartmentalization of integral plasma membrane proteins by hepatocytes and their progenitors in the rat pancreas J Cell Sci 98 1 45 54
302. GW McCaughan et al. 1990 Identification of the bile canalicular cell surface molecule GP110 as the ectopeptidase dipeptidyl peptidase IV: an analysis by tissue distribution, purification and N-terminal amino acid sequence Hepatology 11 4 534 544
303. GW McCaughan et al. 2000 Molecular pathogenesis of liver disease: an approach to hepatic inflammation, cirrhosis and liver transplant tolerance Immunol Rev 174 172 191
304. RJ O'Hara et al. 1998 Impaired interleukin-12 production is associated with a defective anti-tumour response in colorectal cancer Dis Colon Rectum 41 4 460 463
305. OJ Cordero et al. 1997 Interleukin-12 enhances CD26 expression and dipeptidyl peptidase IV function on human activated lymphocytes Immunobiology 197 5 522 533
306. Y Kasahara et al. 1984 Glycylprolyl-diaminopeptidase in human leukocytes: selective occurrence in T lymphocytes and influence on the total serum enzyme activity Clin Chim Acta 139 3 295 302
307. PE Ward 1984 Immunoelectrophoretic analysis of vascular, membrane-bound angiotensin I converting enzyme, aminopeptidase M, and dipeptidyl(amino) peptidase IV Biochem Pharmacol 33 20 3183 3193
308. S Mentzel et al. 1996 Organ distribution of aminopeptidase A and dipeptidyl peptidase IV in normal mice J Histochem Cytochem 44 5 445 461
309. Z Lojda 1979 Studies on dipeptidyl(amino)peptidase IV (glycyl-proline naphthylamidase). II. Blood vessels Histochemistry 59 3 153 166
310. V van der Velden et al. 1998 Expression of aminopeptidase N and dipeptidyl peptidase IV in the healthy and asthmatic bronchus Clin Exp Allergy 28 1 110 120
311. R Gossrau 1979 Peptidases II. Localization of dipeptidylpeptidase IV (DPP IV). Histochemical and biochemical study Histochemistry 60 2 231 248
312. N Sahara et al. 1983 Immunohistochemical localization of dipeptidyl peptidase IV in rat digestive organs Acta Histochem Cytochem 16 494 501
313. L Pala et al. 2003 Dipeptidyl peptidase-IV expression and activity in human glomerular endothelial cells Biochem Biophys Res Commun 310 1 28 31
314. JC Mavropoulos et al. 2005 Anti-tumor necrosis factor-alpha therapy augments dipeptidyl peptidase IV activity and decreases autoantibodies to GRP78/BIP and phosphoglucose isomerase in patients with rheumatoid arthritis J Rheumatol 32 11 2116 2124
315. T Uematsu M Urade M Yamaoka 1998 Decreased expression and release of dipeptidyl peptidase IV (CD26) in cultured peripheral blood T lymphocytes of oral cancer patients J Oral Pathol Med 27 3 106 110
316. T Uematsu et al. 2004 Effects of oral squamous cell carcinoma-derived TGF-beta1 on CD26/DPPIV expression in T cells Anticancer Res 24 2B 619 624
317. Z Lojda 1981 Proteinases in pathology. Usefulness of histochemical methods J Histochem Cytochem 29 3A Suppl 481 493
318. Z Lojda 1985 The importance of protease histochemistry in pathology Histochem J 17 10 1063 1089
319. Z Lojda 1988 Dipeptidyl peptidases of human lymphocytes Czech Med 11 4 181 194
320. US Sehmsdorf et al. 2004 Human miscarriage is associated with increased number of CD26 decidual lymphocytes Scand J Immunol 59 4 400 407
321. D Scheel-Toellner et al. 1995 CD26 expression in leprosy and other granulomatous diseases correlates with the production of interferon-gamma Lab Invest 73 5 685 690
322. M Willheim et al. 1997 Cell surface characterization of T lymphocytes and allergen-specific T cell clones: correlation of CD26 expression with T(H1) subsets J Allergy Clin Immunol 100 3 348 355
323. A Cavani et al. 2000 Human CD4+ T lymphocytes with remarkable regulatory functions on dendritic cells and nickel-specific Th1 immune responses J Invest Dermatol 114 2 295 302
324. A Müller et al. 2000 Localized Wegener's granulomatosis: predominance of CD26 and IFN-gamma expression J Pathol 192 1 113 120
325. EP Boonacker et al. 2002 CD26/DPPIV signal transduction function, but not proteolytic activity, is directly related to its expression level on human Th1 and Th2 cell lines as detected with living cell cytochemistry J Histochem Cytochem 50 9 1169 1177
326. RP Schade et al. 2002 Cell-surface expression of CD25, CD26, and CD30 by allergen-specific T cells is intrinsically different in cow's milk allergy J Allergy Clin Immunol 109 2 357 362
327. K Nakao et al. 2002 Serum levels of soluble CD26 and CD30 in patients on hemodialysis Nephron 91 2 215 221
328. MT Fierro et al. 2006 Expression pattern of chemokine receptors and chemokine release in inflammatory erythroderma and Sézary syndrome Dermatology 213 4 284 292
329. M Krakauer PS Sorensen F Sellebjerg 2006 CD4(+) memory T cells with high CD26 surface expression are enriched for Th1 markers and correlate with clinical severity of multiple sclerosis J Neuroimmunol 181 1-2 157 164
330. R Jafari-Shakib et al. 2008 CD26 expression on CD4+ T cells in patients with cutaneous leishmaniasis Clin Exp Immunol 153 1 31 36
331. F Ilhan et al. 2008 Th1 polarization of the immune response in uveitis in Behçet's disease Can J Ophthalmol 43 1 105 108
332. Y Ma et al. 2008 The CD4+ CD26- T-cell population in classical Hodgkin's lymphoma displays a distinctive regulatory T-cell profile Lab Invest 88 5 482 490
333. C Cordon-Cardo C Prives 1999 At the crossroads of inflammation and tumorigenesis J Exp Med 190 10 1367 1370
334. Dvorak-HF 1986 Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing N Engl J Med 315 26 1650 1659
335. RM Strieter et al. 2004 CXC chemokines: angiogenesis, immunoangiostasis, and metastases in lung cancer Ann N Y Acad Sci 1028 12 351 360
336. PW Szlosarek FR Balkwill 2003 Tumour necrosis factor alpha: a potential target for the therapy of solid tumours Lancet Oncol 4 9 565 573
337. JB Byrd et al. 2007 Dipeptidyl peptidase IV deficiency increases susceptibility to angiotensin-converting enzyme inhibitor-induced peritracheal edema J Allergy Clin Immunol 120 2 403 408
338. TA Waldmann 2006 Effective cancer therapy through immunomodulation Annu Rev Med 57 65 81
339. W Zou et al. 2001 Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells Nat Med 7 12 1339 1346
340. E Hartmann et al. 2003 Identification and functional analysis of tumor-infiltrating plasmacytoid dendritic cells in head and neck cancer Cancer Res 63 19 6478 6487
341. TJ Curiel et al. 2004 Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival Nat Med 10 9 942 949
342. E Giovannucci 2001 Insulin, insulin-like growth factors and colon cancer: a review of the evidence J Nutr 131 11 Suppl 3109 3120
343. K Masur et al. 2006 DPPIV inhibitors extend GLP-2 mediated tumour promoting effects on intestinal cancer cells Regul Pept 137 3 147 155
344. JM Lenhard DK Croom DT Minnick 2004 Reduced serum dipeptidyl peptidase-IV after metformin and pioglitazone treatments Biochem Biophys Res Commun 324 1 92 97
345. CH Wang et al. 2008 Cyclosporine increases ischemia-induced endothelial progenitor cell mobilization through manipulation of the CD26 system Am J Physiol Regul Integr Comp Physiol 294 3 R811 R818
346. DT Dang et al. 2008 Hypoxia-inducible factor-1 target genes as indicators of tumor vessel response to vascular endothelial growth factor inhibition Cancer Res 68 6 1872 1880
347. G Ghersi et al. 2001 Critical role of dipeptidyl peptidase IV in neuropeptide Y-mediated endothelial cell migration in response to wounding Peptides 22 3 453 458
348. JA Thompson et al. 2008 Phase I study of recombinant interleukin-21 in patients with metastatic melanoma and renal cell carcinoma J Clin Oncol 26 12 2034 2039
349. M Dougan G Dranoff 2009 Immune therapy for cancer Annu Rev Immunol 27 83 117
350. CE Rolle R Carrio TR Malek 2008 Modeling the CD8+ T effector to memory transition in adoptive T-cell antitumor immunotherapy Cancer Res 68 8 2984 2992
351. X Duan et al. 2009 Murine bone marrow-derived mesenchymal stem cells as vehicles for interleukin-12 gene delivery into Ewing sarcoma tumors Cancer 115 1 13 22
352. S Park S Cheon D Cho 2007 The dual effects of interleukin-18 in tumor progression Cell Mol Immunol 4 5 329 335
353. S Mocellin D Nitti 2008 TNF and cancer: the two sides of the coin Front Biosci 13 2774 2783
354. S Mocellin et al. 2005 Tumor necrosis factor, cancer and anticancer therapy Cytokine Growth Factor Rev 16 1 35 53